0001493152-24-010408.txt : 20240319 0001493152-24-010408.hdr.sgml : 20240319 20240319060439 ACCESSION NUMBER: 0001493152-24-010408 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240318 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hartford Great Health Corp. CENTRAL INDEX KEY: 0001482554 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] ORGANIZATION NAME: 06 Technology IRS NUMBER: 205422795 STATE OF INCORPORATION: NV FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54439 FILM NUMBER: 24760996 BUSINESS ADDRESS: STREET 1: 8832 GLENDON WAY CITY: ROSEMEAD STATE: CA ZIP: 91770 BUSINESS PHONE: 626-656-6192 MAIL ADDRESS: STREET 1: 8832 GLENDON WAY CITY: ROSEMEAD STATE: CA ZIP: 91770 FORMER COMPANY: FORMER CONFORMED NAME: Photoamigo, Inc. DATE OF NAME CHANGE: 20100128 8-K 1 form8-k.htm
false 0001482554 0001482554 2024-03-18 2024-03-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 18, 2024

 

HARTFORD GREAT HEALTH CORP.

 

(Exact name of registrant as specified in its charter)

 

Nevada   000-54439   51-0675116
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

8832 Glendon Way, Rosemead, California   91770
(Address of principal executive offices)   (Zip Code)

 

626-321-1915

Registrant’s telephone number, including area code

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s) Name of each exchange on which registered
Common stock, par value $0.001 par value   HFUS   OTC Markets Group

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Departure of Chief Executive Officer

 

On March 18, 2024, Ms. Rose Hong Wang, Chief Executive Officer of Hartford Great Health Corp. (the “Company”), tendered her resignation from such position effective April 1, 2024. Ms. Wang’s notice of resignation is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or procedures. Ms. Wang will not be entitled to any compensation, payments or benefits from the Company or affiliates in connection with her resignation.

 

Chief Executive Officer Appointment

 

Upon Ms. Wang’s departure on April 1, 2024, the Company intends to appoint Mr. Sheng-Yih Chang as Chief Executive Officer. Mr. Chang has also tendered his resignation on March 18, 2024 from the position of Chief Financial Officer of the Company, to be effective on April 1, 2024. Mr. Chang has served as the Chief Financial Officer of the Company since June 2018, and the General Manager at Hartford Hotel, a commercial hotel in Rosemead California since March 2018. Mr. Chang served as a Product Manager at Jowett Group, a textile manufacturing company in the USA, from November 2015 through September 2017, as an Operational Manager and General Manager at A-Concepts Designs, a houseware supplier company in the USA, from January 2004 through October 2015, as a General Manager at Long Arch International, a carving crafts supplier in the USA, from December 2000 through December 2003, as a Sales Manager at EZ Wholesale, a general merchandise wholesaler in the USA, from July 1998 through November 2000, and as a technician at Richcom Computer Corporation, a computer service provider in California, from July 1996 through November 1997. Mr. Chang studied electrical engineering at the University of British Columbia and holds a Bachelor of Science in Electrical Engineering from California State University, Northridge.

 

Appointment of Interim Chief Financial Officer

 

In connection with Mr. Chang’s resignation of Chief Financial Officer, on March 18, 2024, the Company entered into an interim CFO Consulting Agreement (the “Consulting Agreement”) with Green-Keen Consulting LLC (“GKC”), pursuant to which the Company appointed Ms. Lili Dai as interim Chief Financial Officer, to be effective April 1, 2024, with a term ending March 31, 2025. Pursuant to the Consulting Agreement, the Company will pay GKC a fixed monthly payment of $13,300. The Company will also be billed for travel and other out-of-pocket costs, such as report production, postage, etc., if any.

 

Ms. Lili Dai, age 47, joined GKC in December 2023 and currently chairs their consulting practice. Ms. Dai possesses a diverse background encompassing accounting, auditing, financial reporting, and management. Since August 2023, she has served as Interim VP Controller at Inno Holdings Inc. and played a pivotal role in its successful IPO process. Prior to that, from September 2021 to August 2023, she held the position of Director of Technical Accounting and Reporting at Tattooed Chef LLC, where she oversaw technical accounting matters and external financial reporting. From January 2018 to September 2021, Ms. Dai served as the Director of Accounting and Financial Reporting at Markwins Beauty Brands, responsible for managing global operational accounting and reporting functions. Earlier in her career, from October 2015 to December 2017, she worked as a Senior Technical Corporate Accountant at a multi-billion-dollar company, Monster Energy Drink. Ms. Dai’s tenure at PwC Los Angeles, from January 2012 to October 2015, involved supervising audit engagements for several large companies across diverse industries. She began her professional journey as an auditor at Frazer LLP, a regional CPA firm in California, from April 2008 to December 2011. Ms. Dai holds a Master of Science in Accountancy from California State University Fullerton and is an active Certified Public Accountant.

 

There is no arrangement or understanding between Ms. Dai and any other persons pursuant to which Ms. Dai was selected as an officer.

 

There are no family relationships between Ms. Dai and any director, executive officer or person nominated or chosen by the Company to become a director or executive officer of the Company within the meaning of Item 401(d) of Regulation S-K under the U.S. Securities Act of 1933 (“Regulation S-K”).

 

The description of the Consulting Agreement does not purport to be complete and is subject to, and qualified in its entirety by reference to, the Consulting Agreement, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit Number   Description
10.1   ICFO Consulting Agreement, dated as of March 18, 2024, between Hartford Great Health Corp. and Green-Keen Consulting LLC
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  HARTFORD GREAT HEALTH CORP.
   
Dated: March 19, 2024 By: /s/ Sheng-Yih Chang
    Sheng-Yih Chang
    Chief Financial Officer

 

 

 

 EX-10.1 2 ex10-1.htm

 

Exhibit 10.1

 

Green-Keen Consulting LLC

440 N Barranca Ave. #9781,

Covina, CA 91723

 

  March 18, 2024

 

Hartford Great Health Corp

8832 Glendon Way,

Rosemead, California 91770

 

Mr. Stanley Chang:

 

In order to document the understanding between as to the scope of the work that Green-Keen Consulting LLC (“GKC” or “we”) will perform, as well as certain other matters, we are entering into this Agreement with Hartford Great Health Corp. (“you” or the “Company”). To avoid any misunderstandings, this Agreement defines the services we will perform for you as well as your responsibilities.

 

SCOPE OF WORK

 

We will provide an Interim Chief Financial Officer (“ICFO”) to the Company. The named ICFO will be Lili Dai. The ICFO will be responsible for:

 

  1. Financial Strategy and Compliance:

 

  ◌ Collaborate with management, financial analyst, legal counsel, auditor and investment banking teams.
  ◌ Assist to comply with NASDAQ listing requirements and the Securities & Exchange Commission (SEC) reporting requirements.
  ◌ Evaluate corporate governance standards. Liaising with management and the board for general communications.

 

2.Financial Reporting and Uplisting Readiness:

 

  ◌ Oversee financial reporting processes.
  ◌ Prepare financial statements for inclusion in the forms to be filed with SEC and NASDAQ listing application.
  ◌ Assist in due diligence processes.
  ◌ Provide strategic advice relating to future development of the finance team.
  ◌ Assist in accounting for complex financial instruments and other complex accounting transactions, such as the valuation, recognition, reporting and disclosure of all equity transactions.
  ◌ Take responsibility to sign Forms 10-Q and 10-K (and the related certifications), as well as other financially oriented filings with the SEC (such as registration statements), as the Company’s ICFO and Principal Financial and Accounting Officer.

 

PRICING

 

We will perform the monthly services at a fixed monthly rate of $13,300, billed and payable on the 20th of every month, commencing April 20, 2024. The Company will also be billed for travel and other out-of-pocket costs, such as report production, postage, etc.

 

 
 

 

THE COMPANY SPECIFICALLY ACKNOWLEDGES AND AGREES TO THE FOLLOWING:

 

  ◌ We will assign Lili Dai, the principal of our consulting practice to perform ICFO services and the Company’s CEO will oversee the Services that Lili Dai will perform.
  ◌ In connection with the Services listed within “Scope of Services”, the ICFO will provide all related services based on all data and documents provided by the Company. However, the Services will not constitute an engagement to provide audit, review or attest services as described in the pronouncements on professional standards issued by the AICPA, and, therefore, we will not express an opinion or any other form of assurance with respect to the Company’s compliance with laws, regulations or other matters (including, without limitation, the Company’s required disclosures).
  ◌ The ICFO will not make management decisions.
  ◌ The ICFO will not be providing any legal advice or conducting a legal review of any of the Company’s documents, records, or policies.
  ◌ The nature, scope, and design of the Services that the ICFO is requested to perform are solely the responsibility of the Company.
  ◌ Our procedures are limited in nature and do not extend to all matters of the Company.
  ◌ The Company is responsible for procuring Directors and Officers (D&O) insurance to provide coverage for the services rendered by the ICFO.

 

Term

 

This Agreement will commence on April 1, 2024 and will continue in effect until March 31, 2025. It is understood that either party may terminate this Agreement at any time, for any reason, within 30 days of written notice to the other party. It is understood that any unpaid services that are outstanding at the date of termination are to be paid in full within 10 days from the date of termination. Any and all financial and other information in GKC’s possession at the time of termination must be turned over to the Company, including but not limited to quarterly and annual financial statements, accompanying footnotes, workpapers, MD&A, proposed adjustments with supporting documentation, any other work product prepared by GKC on behalf of the Company.

 

E-mail Communication

 

In connection with this engagement, we may communicate with you or others via e-mail transmission. As e-mails can be intercepted and read, disclosed, or otherwise used or communicated by an unintended third party, or may not be delivered to each of the parties to whom they are directed and only to such parties, we cannot guarantee or warrant that e-mails from us will be properly delivered and read only by the addressee. Therefore, we specifically disclaim any liability or responsibility whatsoever for interception or unintentional disclosure or communication of e-mail transmissions, or for the unauthorized use or failed delivery of e-mails transmitted by us in connection with the performance of this engagement. In that regard, you agree that we shall have no liability for any loss or damage to any person or entity resulting from the use of e-mail transmissions, including any consequential, incidental, direct, indirect, or special damages, such as loss of revenues or anticipated profits, or disclosure or communication of confidential or proprietary information.

 

Compelled Disclosure

 

In the event that we or any of its members, officers and employees are requested or become legally compelled (by oral questions, interrogatories, request for information or documents, subpoena, civil investigative demand or similar process) to disclose any information regarding the Company or the services provided hereunder, the Company (to the extent permitted) will be provided with prompt written notice thereof, so that the Company may seek a protective order or other appropriate remedy at its own option and expense. The Company shall reimburse us for all costs and expenses, including attorneys’ fees, which we and its members, officers and employees incur in connection with such requested or compelled disclosure, whether or not any such protective order or other remedy is sought or obtained.

 

 
 

 

Indemnification

 

The Company shall defend, indemnify, and hold us and its members, officers and employees, harmless from and against all claims asserted by a third party (or parties) and related damages, losses, or expenses, including, but not limited, to attorneys’ fees arising out of or resulting from any and all acts or omissions of the Company or its affiliates, including, but not limited to acts or omissions in the maintenance of the Company’s books, records, and accounts, in the preparation or use of the Company’s financial statements, in the timely filing of reports, statements, and other documents with the U.S. Securities and Exchange Commission, and in the design and maintenance of disclosure controls and procedures and internal control over financial reporting.

 

Limitation on Liability

 

Our maximum liability hereunder for any reason shall be limited to the aggregate amount of the fees paid by the Company to us for the six months immediately preceding the date of the applicable claim. UNDER NO CIRCUMSTANCES SHALL WE BE LIABLE FOR ANY SPECIAL, INDIRECT, INCIDENTAL, PUNITIVE, EXEMPLARY OR CONSEQUENTIAL LOSS OR DAMAGE RELATING TO THIS AGREEMENT. This limitation on liability provision shall apply to the fullest extent of the law, whether any claims are based in contract, statute, tort, or otherwise.

 

Waiver

 

The failure of any party to this Agreement at any time to require the performance of any provision of this Agreement shall in no manner affect the right to enforce the same, and no waiver by any party to this Agreement of any provision of this Agreement (whether by conduct or otherwise) shall be deemed or construed as a further or continuing waiver of such provision or any other provision of this Agreement.

 

Third-Party Rights

 

No provision of this Agreement shall in any way inure to the benefit of any third person (including the public at large) so as to make any such person a third-party beneficiary of this Agreement or of any one or more of the terms hereof, or otherwise give rise to any cause of action in any person not a party hereto.

 

Severability

 

If any provision of this Agreement, as applied to any party or to any circumstances, shall be found by a court of competent jurisdiction to be void, invalid, or unenforceable, the same shall in no way affect any other provision of this Agreement, the application of any such provision in any other circumstances, or the validity or enforceability of this Agreement.

 

Entire Agreement

 

This Agreement contains the entire understanding of the parties hereto relating to the subject matter of this Agreement and supersedes all prior and collateral agreements, understandings, statements, and negotiations of the parties.

 

Governing Law

 

This Agreement shall be governed by and construed in accordance with the laws of the State of California without regard to any laws that might otherwise govern under applicable principles of conflicts of laws.

 

Dispute Resolution

 

If any dispute arises among the parties, they agree to try first in good faith to settle the dispute by mediation administered by the American Arbitration Association (AAA) under its Commercial Mediation Rules. All unresolved disputes shall then be decided by final and binding arbitration in accordance with the Commercial Arbitration Rules of the AAA. In agreeing to arbitration, we both acknowledge that in the event of a dispute over fees, each of us is giving up the right to have the dispute decided in a court of law before a judge or jury and instead we are accepting the use of arbitration for resolution. In any litigation, arbitration, or other proceeding by which one party either seeks to enforce its rights under this Agreement (whether in contract, tort, or both) or seeks a declaration of any rights or obligations under this Agreement, the prevailing party shall be awarded its reasonable attorney fees, and costs and expenses incurred.

 

We would like to take this opportunity to express our appreciation for the opportunity to offer our services to your organization.

 

Very truly yours,

 

Green-Keen Consulting LLC

 

 
Lili Dai,  
Principal  

 

Acceptance:

 

This letter correctly sets forth the understanding of Hartford Great Health Corp.

 

By:  
  Sheng-Yih Chang  
Title: Chief Financial Officer  

 

Date: March 18, 2024

 

 

 

 GRAPHIC 3 ex10-1_001.jpg begin 644 ex10-1_001.jpg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end GRAPHIC 4 ex10-1_002.jpg begin 644 ex10-1_002.jpg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end EX-101.SCH 5 hfus-20240318.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 hfus-20240318_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 7 hfus-20240318_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover
Mar. 18, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 18, 2024
Entity File Number 000-54439
Entity Registrant Name HARTFORD GREAT HEALTH CORP.
Entity Central Index Key 0001482554
Entity Tax Identification Number 51-0675116
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 8832 Glendon Way
Entity Address, City or Town Rosemead
Entity Address, State or Province CA
Entity Address, Postal Zip Code 91770
City Area Code 626
Local Phone Number 321-1915
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, par value $0.001 par value
Trading Symbol HFUS
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://hartfordhealthcare.org/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm hfus-20240318.xsd hfus-20240318_lab.xml hfus-20240318_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "HFUS", "nsuri": "http://hartfordhealthcare.org/20240318", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "hfus-20240318.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "hfus-20240318_lab.xml" ] }, "presentationLink": { "local": [ "hfus-20240318_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://hartfordhealthcare.org/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-03-18", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-18", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://hartfordhealthcare.org/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 17 0001493152-24-010408-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-010408-xbrl.zip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end XML 19 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001482554 2024-03-18 2024-03-18 iso4217:USD shares iso4217:USD shares false 0001482554 8-K 2024-03-18 HARTFORD GREAT HEALTH CORP. NV 000-54439 51-0675116 8832 Glendon Way Rosemead CA 91770 626 321-1915 false false false false Common stock, par value $0.001 par value HFUS true false